Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 9/20 | 0.84 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 9/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1982122 | 1.00 | CYP2C9 (0.84) | CYP2C9CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL12561613 | 1.00 | CYP2C9 (0.84) | CYP2C9CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL1816910 | 0.91 | CYP2C9 (1.00) | CYP2C9CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL1816655 | 0.88 | CYP1A2 (0.78) | CYP2C9CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL1816983 | 0.87 | CYP2C9 (0.82) | CYP2C9CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL1815615 | 0.86 | CYP2C9 (0.89) | CYP2C9CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL1819884 | 0.85 | CYP3A4 (0.73) | CYP2C9CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL1817961 | 0.85 | CYP2C9 (0.79) | CYP2C9CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL1815098 | 0.85 | CYP2C9 (0.79) | CYP2C9CYP1A2CYP3A4CYP2C19 | |
| SCHEMBL16272814 | 0.85 | CYP2C19 (0.61) | CYP2C9CYP1A2CYP3A4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2501236-B1 | N-[2-fluoro-3-(4-amino-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-phenyl]-4-benzenesulfonamide derivatives as Raf protein kinase modulators for the treatment of cancer | PLEXXIKON INC (US) | 2017-03-29 | — | — | EP | claimed |